secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABVC BIOPHARMA, INC. (ABVC)
CIK:        0001173313
Form:       8-K/A
Filed at:   2025-05-14T23:59:59+00:00
Accession:  0001213900-25-043354
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ABVC BioPharma raises ~$619k via unregistered share sales to non-U.S. persons
-----------------------------------------------------------------------------

- On April 30, 2025 sold 724,372 shares for ~$436k to 15 non-U.S. persons under Regulation S.
- Additional subscriptions from May 9-13, 2025: 306,041 shares for ~$183,625 from 7 non-U.S. persons.
- Each investor transferred voting rights to chairman Eugene Jiang via Voting Rights Proxy Agreement.
- Shares are unregistered, restricted for one year, and sold without general solicitation.
- Total gross proceeds from both tranches approximate $619,625.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1173313/000121390025043354/0001213900-25-043354-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1173313/000121390025043354/ea0241575-8ka_abvcbio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-043354

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer